Ontology highlight
ABSTRACT:
SUBMITTER: Qiu Q
PROVIDER: S-EPMC6800263 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
Qiu Qiang Q Li Mengyuan M Yang Linyu L Tang Minghai M Zheng Li L Wang Fang F Qiu Huandi H Liang Cailing C Li Ning N Yi Dongni D Yi Yuyao Y Pan Cong C Yang Shengyong S Chen Lijuan L Hu Yiguo Y
Oncotarget 20191015 57
Multiple myeloma (MM) pathogenesis remains incompletely understood and biomarkers predicting treatment response still remain lacking. Here we describe the rational mechanisms of combining targeting glautaminase1 (GLS1) with other chemo-reagents for MM treatment. Gls1 is highly expressed cMYC/KRAS12V-drived plasmacytoma (PCT) cells. Down-regulation of Gls1 with miRNAi in cMYC/KRAS12V-expressing BaF3 cells prevented them from growing independence of interleukin 3 (IL3). By using our cMYC/KRAS12V-t ...[more]